ALKEMPharmaceuticals
Alkem Laboratories Ltd — Balance Sheet
₹5299.00
-1.40%
Alkem Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 11.96 Cr | 11.96 Cr | 11.96 Cr | 11.96 Cr | — |
| Share Issued | 11.96 Cr | 11.96 Cr | 11.96 Cr | 11.96 Cr | — |
| Net Debt | 758.65 Cr | 758.90 Cr | 1.03K Cr | 2.35K Cr | — |
| Total Debt | 1.38K Cr | 1.42K Cr | 1.40K Cr | 2.67K Cr | — |
| Tangible Book Value | 11.45K Cr | 9.84K Cr | 8.55K Cr | 8.16K Cr | — |
| Invested Capital | 13.05K Cr | 11.53K Cr | 10.35K Cr | 11.22K Cr | — |
| Working Capital | 6.98K Cr | 6.42K Cr | 5.02K Cr | 3.63K Cr | — |
| Payables | 2.40K Cr | 2.21K Cr | 1.54K Cr | 1.51K Cr | — |
| Net Tangible Assets | 11.45K Cr | 9.84K Cr | 8.55K Cr | 8.16K Cr | — |
| Capital Lease Obligations | 318.11 Cr | 204.44 Cr | 89.53 Cr | 88.07 Cr | — |
| Common Stock Equity | 11.98K Cr | 10.31K Cr | 9.05K Cr | 8.64K Cr | — |
| Total Capitalization | 12.30K Cr | 10.35K Cr | 9.05K Cr | 8.65K Cr | — |
| Total Equity Gross Minority Interest | 12.43K Cr | 10.71K Cr | 9.44K Cr | 8.85K Cr | — |
| Minority Interest | 448.76 Cr | 402.34 Cr | 389.71 Cr | 209.43 Cr | — |
| Stockholders Equity | 11.98K Cr | 10.31K Cr | 9.05K Cr | 8.64K Cr | — |
| Other Equity Interest | 36.15 Cr | 19.54 Cr | 0.60 Cr | 0.60 Cr | — |
| Retained Earnings | 9.97K Cr | 8.31K Cr | 7.05K Cr | 6.59K Cr | — |
| Capital Stock | 23.91 Cr | 23.91 Cr | 23.91 Cr | 23.91 Cr | — |
| Common Stock | 23.91 Cr | 23.91 Cr | 23.91 Cr | 23.91 Cr | — |
| Total Liabilities Net Minority Interest | 5.26K Cr | 4.86K Cr | 4.32K Cr | 5.22K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 1.29K Cr | 865.95 Cr | 614.50 Cr | 416.52 Cr | — |
| Other Non Current Liabilities | 21.95 Cr | 25.84 Cr | -0.02 Cr | 7.92 Cr | — |
| Derivative Product Liabilities | 224.42 Cr | 196.56 Cr | — | — | — |
| Non Current Pension And Other Postretirement Benefit Plans | 338.22 Cr | 299.86 Cr | — | — | — |
| Tradeand Other Payables Non Current | 1.98 Cr | — | — | — | — |
| Non Current Deferred Revenue | 21.95 Cr | 25.84 Cr | 8.80 Cr | 7.92 Cr | — |
| Long Term Debt And Capital Lease Obligation | 578.33 Cr | 229.26 Cr | 70.33 Cr | 75.85 Cr | — |
| Long Term Capital Lease Obligation | 267.42 Cr | 189.26 Cr | 70.33 Cr | 66.47 Cr | — |
| Long Term Debt | 310.91 Cr | 40.00 Cr | 0.00 | 9.38 Cr | — |
| Long Term Provisions | 338.22 Cr | 299.86 Cr | 369.36 Cr | 332.75 Cr | — |
| Current Liabilities | 3.96K Cr | 3.99K Cr | 3.71K Cr | 4.81K Cr | — |
| Other Current Liabilities | 305.70 Cr | 229.65 Cr | 0.01 Cr | 150.32 Cr | — |
| Current Debt And Capital Lease Obligation | 802.57 Cr | 1.19K Cr | 1.33K Cr | 2.59K Cr | — |
| Current Capital Lease Obligation | 50.69 Cr | 15.18 Cr | 19.20 Cr | 21.60 Cr | — |
| Current Debt | 751.88 Cr | 1.17K Cr | 1.31K Cr | 2.57K Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 159.11 Cr | 126.87 Cr | — | 273.60 Cr | 236.64 Cr |
| Current Provisions | 159.11 Cr | 126.87 Cr | 372.75 Cr | 273.60 Cr | — |
| Other Payable | 496.27 Cr | 403.95 Cr | 349.68 Cr | 319.72 Cr | — |
| Dividends Payable | 0.17 Cr | 0.17 Cr | 0.20 Cr | 0.18 Cr | — |
| Total Tax Payable | 61.10 Cr | 54.99 Cr | 23.44 Cr | 16.32 Cr | — |
| Accounts Payable | 1.84K Cr | 1.75K Cr | 1.17K Cr | 1.17K Cr | — |
| Total Assets | 17.69K Cr | 15.57K Cr | 13.76K Cr | 14.07K Cr | — |
| Total Non Current Assets | 6.75K Cr | 5.16K Cr | 5.03K Cr | 5.63K Cr | — |
| Other Non Current Assets | -0.03 Cr | -0.01 Cr | -0.01 Cr | 0.02 Cr | — |
| Non Current Prepaid Assets | 374.31 Cr | 87.10 Cr | 81.53 Cr | 101.13 Cr | — |
| Non Current Deferred Taxes Assets | 1.74K Cr | 1.51K Cr | 1.30K Cr | 1.31K Cr | — |
| Investmentin Financial Assets | 1.04K Cr | 405.38 Cr | 564.62 Cr | 910.65 Cr | — |
| Held To Maturity Securities | 710.39 Cr | 170.40 Cr | 142.67 Cr | 105.08 Cr | — |
| Available For Sale Securities | 835.78 Cr | 240.98 Cr | 260.01 Cr | 678.98 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 200.47 Cr | 164.40 Cr | 161.94 Cr | 126.59 Cr | — |
| Long Term Equity Investment | 32.38 Cr | 0.00 | — | — | — |
| Investmentsin Associatesat Cost | 32.38 Cr | 0.00 | — | — | — |
| Goodwill And Other Intangible Assets | 537.68 Cr | 474.32 Cr | 492.55 Cr | 475.28 Cr | — |
| Other Intangible Assets | 114.57 Cr | 57.58 Cr | 79.38 Cr | 72.19 Cr | — |
| Goodwill | 423.11 Cr | 416.74 Cr | 413.17 Cr | 403.09 Cr | — |
| Net PPE | 2.93K Cr | 2.60K Cr | 2.51K Cr | 2.77K Cr | — |
| Accumulated Depreciation | -1.67K Cr | -1.38K Cr | -1.12K Cr | -1.07K Cr | — |
| Gross PPE | 4.60K Cr | 3.97K Cr | 3.63K Cr | 3.84K Cr | — |
| Construction In Progress | 545.69 Cr | 186.87 Cr | 310.27 Cr | 339.48 Cr | — |
| Other Properties | 2.39K Cr | 247.17 Cr | 137.86 Cr | 139.35 Cr | — |
| Machinery Furniture Equipment | 2.48K Cr | 2.37K Cr | 2.17K Cr | 2.26K Cr | — |
| Buildings And Improvements | 1.42K Cr | 1.03K Cr | 878.60 Cr | 967.17 Cr | — |
| Land And Improvements | 151.89 Cr | 136.46 Cr | 136.91 Cr | 137.25 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 10.95K Cr | 10.41K Cr | 8.73K Cr | 8.44K Cr | — |
| Other Current Assets | 18.54 Cr | 21.42 Cr | 22.11 Cr | 22.67 Cr | — |
| Assets Held For Sale Current | 134.63 Cr | 0.00 | 123.26 Cr | 1.73 Cr | — |
| Restricted Cash | 723.22 Cr | 220.50 Cr | 1.79K Cr | 1.40K Cr | — |
| Prepaid Assets | 774.22 Cr | 778.43 Cr | 713.49 Cr | 618.70 Cr | — |
| Inventory | 2.92K Cr | 2.66K Cr | 2.61K Cr | 3.01K Cr | — |
| Finished Goods | 1.87K Cr | 1.65K Cr | 1.64K Cr | 2.08K Cr | — |
| Work In Process | 129.33 Cr | 147.41 Cr | 163.99 Cr | 134.34 Cr | — |
| Raw Materials | 926.59 Cr | 868.52 Cr | 805.84 Cr | 789.97 Cr | — |
| Other Receivables | 128.63 Cr | 207.52 Cr | 197.01 Cr | 184.31 Cr | — |
| Accounts Receivable | 2.47K Cr | 2.25K Cr | 2.13K Cr | 1.88K Cr | — |
| Allowance For Doubtful Accounts Receivable | -79.54 Cr | -91.35 Cr | -43.82 Cr | -46.44 Cr | — |
| Gross Accounts Receivable | 2.55K Cr | 2.34K Cr | 2.18K Cr | 1.93K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 3.78K Cr | 4.27K Cr | 1.14K Cr | 1.31K Cr | — |
| Other Short Term Investments | 3.47K Cr | 3.81K Cr | 869.36 Cr | 1.08K Cr | — |
| Cash And Cash Equivalents | 304.14 Cr | 455.07 Cr | 273.80 Cr | 232.18 Cr | — |
| Cash Equivalents | 107.35 Cr | 0.00 | 74.21 Cr | 3.00 Cr | — |
| Cash Financial | 196.79 Cr | 455.07 Cr | 199.59 Cr | 229.18 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Alkem Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.